Tradestie Institutional Equity Comparison Engine

MGTX vs CVM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MGTX Overall Edge

MGTX Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MeiraGTx Holdings plc Ordinary Shares (MGTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CVM counters with relative strength in Valuation. Fundamentally, MGTX trades at 64.1x Forward P/E with 46.3% operating margin (+8608.6% YoY revenue) versus CVM at 23.0x Forward P/E and 0.0% operating margin (-62.7% YoY). In options structure, MGTX sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro) against CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CVM
MGTX 64.1x vs CVM 23.0x Fwd P/E
Growth & Margin Winner MGTX
Op Margin 46.3% vs 0.0% ยท YoY +8608.6% vs -62.7%
Momentum & Technical Winner MGTX
1Y +7.1% vs -77.5% ยท 52W Pos 26% vs 10%
Options & Structure Winner MGTX
BREAKDOWN (3rd %ile IV) vs BREAKDOWN (N/A IV)
MGTX NASDAQ
MeiraGTx Holdings plc Ordinary Shares
Biological Products, (No Disgnostic Substances)
$8.85
-3.59% 1D
Market Cap $844.2M
1M Return -4.63%
1Y Return +7.14%
Forward P/E 64.1x
Unified AI Score
48.0 / 100 HOLD
Tech 48.0 Fund 57.0 Flow 70.0 Mom 58.9
CVM NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.59
+24.22% 1D
Market Cap $20.9M
1M Return -11.17%
1Y Return -77.48%
Forward P/E 23.0x
Unified AI Score
56.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MGTX +7.14% CVM -77.48% Spread: +84.04 pp (MGTX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MGTX Revenue CVM Revenue MGTX Op. Margin CVM Op. Margin Margin Edge
FY2014 N/A $0M N/A -9721.4% CVM
FY2019 $10M N/A -438.4% N/A MGTX
FY2020 $20M N/A -401.9% N/A MGTX
FY2021 $40M N/A -193.0% N/A MGTX
FY2022 $20M N/A -730.9% N/A MGTX
FY2023 $10M N/A -977.8% N/A MGTX
FY2024 $30M N/A -493.4% N/A MGTX
FY2025 $80M N/A -130.2% N/A MGTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MGTX (8) vs CVM (2)
Institutional Metric MGTX CVM Criterion Row Winner
Market Capitalization Scale $844.2M $20.9M Larger Scale MGTX
Trailing P/E Ratio Valuation 10.1x 23.0x Lower Multiple MGTX
Forward P/E Ratio Valuation 64.1x 23.0x Lower Multiple CVM
Revenue Growth (YoY) Growth +8608.6% -62.7% Higher Growth MGTX
Operating Margin (TTM) Profitability 46.3% 0.0% Higher Margin MGTX
Net Profit Margin Profitability 19.9% 0.0% Higher Margin MGTX
Return on Equity (ROE) Capital Efficiency 72.2% -252.5% Higher ROE MGTX
52-Week Range Position Momentum 26% ($7โ€“$15) 10% ($1โ€“$8) Stronger Trend MGTX
Beta / 30D Volatility Risk Regime 1.65ฮฒ ยท 68% Vol 0.65ฮฒ ยท 120% Vol Lower Realized Risk MGTX
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 56.6 / 100 (HOLD) Higher Composite CVM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MGTX vs CVM Buy Guide
MGTX BREAKDOWN
62d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live MGTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CVM BREAKDOWN
29d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MGTX nor CVM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.